Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days

PURPOSE: Co-administration of the 5α-reductase inhibitor dutasteride increases the oral testosterone bioavailability in men with experimentally induced hypogonadism. We examined oral testosterone with and without dutasteride administration in hypogonadal men for 28 days. MATERIALS AND METHODS: We ra...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Urol
Päätekijät: Amory, John K., Bush, Mark A., Zhi, Hui, Caricofe, Ralph B., Matsumoto, Alvin M., Swerdloff, Ronald S., Wang, Christina, Clark, Richard V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267472/
https://ncbi.nlm.nih.gov/pubmed/21168874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.09.089
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia